POS-VAP Ongoing Observational Study to Support Research on Ventilator Associated Pneumonia in ICU Patients
Led by European Clinical Research Alliance for Infectious Diseases (ECRAID) · Updated on 2026-09-10
20000
Participants Needed
35
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Ventilator-Associated Pneumonia VAP is a common bacterial infection in patients who need mechanical ventilation in the Intensive Care Unit ICU. It increases the risk of death, lengthens hospital stays, raises healthcare costs, and leads to more antibiotic use. This research aims to build and maintain a network of ICUs prepared to conduct future clinical trials to evaluate new prevention and treatment options for VAP.
The study is a perpetual observational study involving adult ICU patients who are expected to be on mechanical ventilation for more than 48 hours. It gathers data continuously from these patients with consent obtained directly or through authorized representatives or waivers as applicable. The study focuses on identifying patients at risk or diagnosed with VAP and tracks subgroups, including those with confirmed infection causes through laboratory tests.
Participants involvement includes monitoring and data collection during their ICU stay with mechanical ventilation. Researchers will measure the number of sites recruiting patients, the number of patients enrolled, and how many studies are conducted through this network over four years. The study also tracks participation in preventive, diagnostic, and treatment studies related to VAP. This ongoing network aims to improve research efficiency and quality in this critical care field.
CONDITIONS
Brief Title
Perpetual Observational Study - Ventilator Associated Pneumonia
Research Team
B
Bruno FRANCOIS, MD
A
Ana HERNANDEZ, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Lead Sponsor
University of Geneva, Switzerland
Collaborating Sponsor
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Age 18 years or older
Admitted or requiring admission to the Intensive Care Unit (ICU)
Expected or documented to be on invasive mechanical ventilation for more than 48 hours
Provided written informed consent, consent from a legally authorized representative, locally accepted consent form, or consent waiver for data collection according to ECRAID principles
You will not qualify if you...
Death is deemed imminent or inevitable during this hospital admission
Patient, substitute decision maker, or attending physician are not committed to full active treatment
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Observation
Duration - Duration of ICU stay under mechanical ventilation
Participants are observed during their ICU stay while receiving mechanical ventilation. Data about their condition and any development of ventilator-associated pneumonia is collected.
Data collected during routine care
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Measuring Lung Function and Pressure During Mechanical Ventilation
in ICU and Surgery Patients Using the PEEP-Step Method
Acyclovir Treatment for Ventilated ICU Patients With Pneumonia and Herpes Simplex Virus in Lung Fluid
Study of Antibiotic Use Strategies for Ventilator Associated Pneumonia in Intensive Care Units
Early Impact Therapy Using Ceftazidime-Avibactam with Rapid Diagnostics Versus Standard Antibiotics in Adults With Bloodstream Infection, Hospital-Acquired or Ventilator-Associated Pneumonia Caused by Resistant Bacteria
Observational Study of Early Biology and Immune Response in Adults With Critical Illness in the ICU
Testing Cotrimoxazole Versus Standard Antibiotics for Ventilator-Associated Pneumonia in ICU Adults A Multicenter Randomized Phase 3 Trial
Oral Care Using Human Milk to Prevent Complications in Very Low Birth Weight Premature Infants in the NICU
Study of Breathing Effort and Lung Function Before and After Extubation in Adults on Mechanical Ventilation
Study of White Blood Cell Role in Acute Lung Injury for Adults on Mechanical Ventilation
POS-VAP Ongoing Observational Study to Support Research on Ventilator Associated Pneumonia in ICU Patients
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases.
Nasreen Hassoun-Kheir, C Henri van Werkhoven, Jake Dunning...